A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine
Open Access
- 1 January 2009
- journal article
- research article
- Published by Medknow in Indian Journal of Psychiatry
- Vol. 51 (4) , 265-71
Abstract
Background: With the advent of newer antipsychotic drugs, side effects such as sexual dysfunction have been a major contributor toward treatment compliance. There are only a few studies that have compared different atypical antipsychotic agents regarding sexual dysfunction. We have not come across any data in this area on Indian population. Aims: To determine and compare the frequency of sexual dysfunction associated with risperidone, olanzapine, and quetiapine, among patients with clinically stable schizophrenia. Settings and Design: It is a cross-sectional hospital-based study. The subjects were recruited for the study by the purposive sampling technique. Materials and Methods: The total sample size was 102, consisting of 25 each in the quetiapine and risperidone groups, 22 in the olanzapine group, and 30 healthy volunteers. A Brief Psychiatric Rating Scale and Sexual Functioning Questionnaire (SFQ) were administered. The Kruskal Wallis test was used to compare the variables in the demographic data and the mean chlorpromazine equivalent doses of the study groups. To analyze the sexual dysfunction, the mean scores on all the domains of sexual functioning in SFQ were compared across the study groups using the Chi square test, for proportions. Results and Conclusion: Twenty-three percent of the healthy volunteers had some impairment in one or more domains of sexual functioning. For the medication groups this was 96, 88, and 90%, respectively for risperidone, quetiapine, and olanzapine. However, there was statistically no significant difference across the study groups although it was relatively less with quetiapine.Keywords
This publication has 22 references indexed in Scilit:
- Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of olanzapine, risperidone, and quetiapineSchizophrenia Research, 2006
- A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophreniaPsychoneuroendocrinology, 2006
- A new atypical antipsychotic: quetiapine-induced sexual dysfunctionsInternational Journal Of Impotence Research, 2004
- A Randomized Open-Label Study of the Impact of Quetiapine Versus Risperidone on Sexual FunctioningJournal of Clinical Psychopharmacology, 2004
- Nithsdale Schizophrenia Surveys 24: sexual dysfunctionThe British Journal of Psychiatry, 2003
- Sexual dysfunction in patients taking conventional antipsychotic medicationThe British Journal of Psychiatry, 2002
- Lithium and Male Sexual Function in Affective PatientsClinical Neuropharmacology, 1996
- Different Patterns of Sexual Dysfunctions Associated with Psychiatric Disorders and Psychopharmacological TreatmentPharmacopsychiatry, 1995
- A pilot study of a structured interview addressing sexual function in men with schizophreniaBiological Psychiatry, 1994
- Sexual Dysfunction and Plasma Prolactin Levels in Neuroleptic-treated Schizophrenic OutpatientsJournal of Nervous & Mental Disease, 1982